5Slreil JM, Jnnes RN ,Sader HS, et al. Assessment of pathogen oeeurrences and resistance profiles among infected patients in the intensive care unlt:report from the SENTRY Antimiero- bial Surveillanee Program ( Nnrlh America , 2001 ) [ J ]. Interna- tional ,Inurnal of Anlimierobial Agents, 2004,24(2) : 111-118.
6Gnmdmann H , Sehrijnemakers P, Bruninsman N , et al. EARSS report on increasing fluoroquinolone resistm：ee among Escheriehia coli in Europe [J]. Clinical Microbiology and In- fections , 2004 , 10 : 64.
7Livennnre DM , Niehol ST, Lamagni TL, et al. Ciprofloxaein resistant Eseheriehia coli from bacteraemias in England;in- creasingly prevalent and mostly from men[J]. Journal of Antimi- crobial Chemotherapy, 2003 , 52 ( 6 ) : 1040-1042.
8Kim HB , Park CH , Kim CJ , et al.Plvvalence of Plas- mid-Mediated Quinolone Resistance Determinants over a 9-Year Period [J ]. Antimicroh Agents Chemother. 2009,53 ( 2 i : 639-645.
9Rodriguez CN, Garcia A , Pastran B.Quinolone antimicmbial resistance in some enterobacteria : a 10-year study in a Venezuelan general hospital[J].International Journal of Amimi- erobial Agents , 2005 , 25 (6) : 546-550.
10Love DE.Quinolone resistance among pneumococci:therapeu- tic and diagnostic implications[Jl. Clin Infect Dis, 2004, 38 (Suppl a) : $357-362.
8Mandell GL, Bennett JE, Raphael D, eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, London: Churchill Livingstone,2000. 821-856,2299-2301.
9Gordon KA, Jones RN. SENTRY participant groups. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America:comparison report to Europe and Latin America: results from the SENTRY antimicrobial surveillance program ( 2000 ). Diagn Microbiol Infect Dis.2003.45,295-301.
10Beidenbach D J, Moet G J, Jones RN. Pathogen occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance program( 1997-2000 ). Diag Microbial Infect Dis ,2004,50:59-69.
6ARIAS A, SERAL C, GUDE M J,et al. Molecular mechanisms of quinolone resistance in clinical isolates of Aeromonas caviae and Aeromonas veronii bv. Sobfia [ J ]. International Microbiology, 2010,13(3) :135 -141.
